API
< Back to situation

[REVISION HISTORY]

Psoriasis health impacts and medical management

1 recorded revision of this situation.

What changed

2026-10-30 02:25 UTC → 2026-10-31 13:16 UTC · added removed

Medical experts are highlighting the complex nature of psoriasis, emphasizing that it is an inflammatory autoimmune disease that is hereditary and non-contagious. While primarily characterized by red, scaly patches on the skin, the condition is linked to significant systemic health risks, including cardiovascular diseases, metabolic disorders, diabetes, and hypertension. Systemic inflammation is specifically noted for increasing the risk of heart attacks and strokes. A major complication is psoriatic arthritis, which affects an estimated 20% to 30% of patients. Experts warn that diagnostic delays can lead to permanent joint damage. Additionally, the disease carries a heavy psychological burden, with studies indicating that up to 62% of individuals experience depression. Patients also report anxiety, shame, and chronic pain, which can impact employment and social relationships. In some regions, data indicates that approximately 61% of patients experience lesions covering more than 10% of their body or affecting sensitive areas like the scalp, face, or joints. On World Psoriasis Day, specialists like Dr. Carolina SepĂșlveda clarified that the condition is not caused by a lack of hygiene. Although there is currently no cure, management strategies include topical creams, skin hydration, phototherapy, immunosuppressants, and biological therapies. Specialists advocate for an integrated medical approach involving dermatology, rheumatology, and psychological support to address both physical and emotional well-being.

Versions

  1. 2026-10-31 13:16 UTC Psoriasis health impacts and medical management
  2. 2026-10-30 02:25 UTC Psoriasis health impacts and medical management

Select a version to see what changed compared to the one before it.